APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled NO Vasodilator

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhaled NO Vasodilator Industry Growth and Trends Forecast to 2032

2 January 202672 pages

Choose your research edition.

Industry ResearchInhaled NO Vasodilator Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled NO Vasodilator Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Inhaled NO Vasodilator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled NO Vasodilator Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled NO Vasodilator Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhaled NO Vasodilator market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhaled NO Vasodilator include Air Liquide, BOC Healthcare (Linde Group), Mallinckrodt and Praxair (Linde plc), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhaled NO Vasodilator market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhaled NO Vasodilator market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhaled NO Vasodilator market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhaled NO Vasodilator.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhaled NO Vasodilator market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhaled NO Vasodilator Market by Company

Air Liquide

BOC Healthcare (Linde Group)

Mallinckrodt

Praxair (Linde plc)

Inhaled NO Vasodilator Segment by Type

800 ppm

100 ppm

Others

Inhaled NO Vasodilator Segment by Application

PPHN

ARDS

Others

Inhaled NO Vasodilator Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled NO Vasodilator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled NO Vasodilator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled NO Vasodilator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaled NO Vasodilator manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhaled NO Vasodilator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 800 ppm Table 2. Major Company of 100 ppm Table 3. Major Company of Others Table 4. Global Inhaled NO Vasodilator Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 6. Global Inhaled NO Vasodilator Sales Market Share in Volume by Type (2021-2026) Table 7. Global Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 8. Global Inhaled NO Vasodilator Sales Market Share in Value by Type (2021-2026) Table 9. Global Inhaled NO Vasodilator Price by Type (2021-2026) & (US$/Unit) Table 10. Global Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 11. Global Inhaled NO Vasodilator Sales Market Share in Volume by Type (2027-2032) Table 12. Global Inhaled NO Vasodilator Sales by Type (2027-2032) & (US$ Million) Table 13. Global Inhaled NO Vasodilator Sales Market Share in Value by Type (2027-2032) Table 14. Global Inhaled NO Vasodilator Price by Type (2027-2032) & (US$/Unit) Table 15. North America Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 16. North America Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 18. Europe Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 22. Latin America Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Inhaled NO Vasodilator Sales by Type (2021-2026) & (US$ Million) Table 25. Inhaled NO Vasodilator Industry Trends Table 26. Inhaled NO Vasodilator Industry Drivers Table 27. Inhaled NO Vasodilator Industry Opportunities and Challenges Table 28. Inhaled NO Vasodilator Industry Restraints Table 29. Global Inhaled NO Vasodilator Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Inhaled NO Vasodilator Revenue Market Share by Company (2021-2026) Table 31. Global Inhaled NO Vasodilator Sales by Company (2021-2026) & (K Units) Table 32. Global Inhaled NO Vasodilator Sales Share by Company (2021-2026) Table 33. Global Inhaled NO Vasodilator Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Inhaled NO Vasodilator Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Inhaled NO Vasodilator Major Company Production Sites and Headquarters Table 36. Global Inhaled NO Vasodilator Company, Product Type & Application Table 37. Global Inhaled NO Vasodilator Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Inhaled NO Vasodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Inhaled NO Vasodilator Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Inhaled NO Vasodilator Sales by Region (2021-2026) & (K Units) Table 42. Global Inhaled NO Vasodilator Sales Market Share in Volume by Region (2021-2026) Table 43. Global Inhaled NO Vasodilator Sales by Region (2021-2026) & (US$ Million) Table 44. Global Inhaled NO Vasodilator Sales Market Share in Value by Region (2021-2026) Table 45. Global Inhaled NO Vasodilator Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Inhaled NO Vasodilator Sales by Region (2027-2032) & (K Units) Table 47. Global Inhaled NO Vasodilator Sales Market Share in Volume by Region (2027-2032) Table 48. Global Inhaled NO Vasodilator Sales by Region (2027-2032) & (US$ Million) Table 49. Global Inhaled NO Vasodilator Sales Market Share in Value by Region (2027-2032) Table 50. Global Inhaled NO Vasodilator Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Inhaled NO Vasodilator Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 53. Global Inhaled NO Vasodilator Sales Market Share in Volume by Application (2021-2026) Table 54. Global Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 55. Global Inhaled NO Vasodilator Sales Market Share in Value by Application (2021-2026) Table 56. Global Inhaled NO Vasodilator Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 58. Global Inhaled NO Vasodilator Sales Market Share in Volume by Application (2027-2032) Table 59. Global Inhaled NO Vasodilator Sales by Application (2027-2032) & (US$ Million) Table 60. Global Inhaled NO Vasodilator Sales Market Share in Value by Application (2027-2032) Table 61. Global Inhaled NO Vasodilator Price by Application (2027-2032) & (US$/Unit) Table 62. North America Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 63. North America Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 65. Europe Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 69. Latin America Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Inhaled NO Vasodilator Sales by Application (2021-2026) & (US$ Million) Table 72. Air Liquide Company Information Table 73. Air Liquide Business Overview Table 74. Air Liquide Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Air Liquide Inhaled NO Vasodilator Product Portfolio Table 76. Air Liquide Recent Development Table 77. BOC Healthcare (Linde Group) Company Information Table 78. BOC Healthcare (Linde Group) Business Overview Table 79. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio Table 81. BOC Healthcare (Linde Group) Recent Development Table 82. Mallinckrodt Company Information Table 83. Mallinckrodt Business Overview Table 84. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mallinckrodt Inhaled NO Vasodilator Product Portfolio Table 86. Mallinckrodt Recent Development Table 87. Praxair (Linde plc) Company Information Table 88. Praxair (Linde plc) Business Overview Table 89. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio Table 91. Praxair (Linde plc) Recent Development Table 92. North America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 94. North America Inhaled NO Vasodilator Sales Market Share by Country (2021-2026) Table 95. North America Inhaled NO Vasodilator Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Inhaled NO Vasodilator Sales Market Share Forecast by Country (2027-2032) Table 97. North America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Inhaled NO Vasodilator Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Inhaled NO Vasodilator Market Share by Country (2021-2026) Table 100. North America Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Inhaled NO Vasodilator Market Share Forecast by Country (2027-2032) Table 102. Europe Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 104. Europe Inhaled NO Vasodilator Sales Market Share by Country (2021-2026) Table 105. Europe Inhaled NO Vasodilator Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Inhaled NO Vasodilator Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Inhaled NO Vasodilator Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Inhaled NO Vasodilator Market Share by Country (2021-2026) Table 110. Europe Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Inhaled NO Vasodilator Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Inhaled NO Vasodilator Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Inhaled NO Vasodilator Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Inhaled NO Vasodilator Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Inhaled NO Vasodilator Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Inhaled NO Vasodilator Market Share by Country (2021-2026) Table 120. Asia-Pacific Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Inhaled NO Vasodilator Market Share Forecast by Country (2027-2032) Table 122. Latin America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 124. Latin America Inhaled NO Vasodilator Sales Market Share by Country (2021-2026) Table 125. Latin America Inhaled NO Vasodilator Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Inhaled NO Vasodilator Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Inhaled NO Vasodilator Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Inhaled NO Vasodilator Market Share by Country (2021-2026) Table 130. Latin America Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Inhaled NO Vasodilator Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Inhaled NO Vasodilator Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Inhaled NO Vasodilator Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Inhaled NO Vasodilator Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Inhaled NO Vasodilator Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Inhaled NO Vasodilator Market Share by Country (2021-2026) Table 140. Middle East and Africa Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Inhaled NO Vasodilator Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Inhaled NO Vasodilator Distributors List Table 145. Inhaled NO Vasodilator Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Inhaled NO Vasodilator Image Figure 2. Global Inhaled NO Vasodilator Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled NO Vasodilator Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled NO Vasodilator Sales (2021-2032) & (K Units) Figure 5. 800 ppm Image Figure 6. Global 800 ppm Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100 ppm Image Figure 8. Global 100 ppm Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Inhaled NO Vasodilator Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Inhaled NO Vasodilator Market Share by Type 2025 VS 2032 Figure 13. North America Inhaled NO Vasodilator Sales Market Share in Volume by Type in 2025 Figure 14. North America Inhaled NO Vasodilator Sales Market Share in Value by Type in 2025 Figure 15. Europe Inhaled NO Vasodilator Sales Market Share in Volume by Type in 2025 Figure 16. Europe Inhaled NO Vasodilator Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Inhaled NO Vasodilator Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Inhaled NO Vasodilator Sales Market Share in Value by Type in 2025 Figure 19. Latin America Inhaled NO Vasodilator Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Inhaled NO Vasodilator Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Inhaled NO Vasodilator Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Inhaled NO Vasodilator Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Inhaled NO Vasodilator Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. PPHN Image Figure 26. Global PPHN Sales YoY Growth (2021-2032) & (K Units) Figure 27. ARDS Image Figure 28. Global ARDS Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Inhaled NO Vasodilator Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Inhaled NO Vasodilator Market Share by Application 2025 VS 2032 Figure 33. North America Inhaled NO Vasodilator Sales Market Share in Volume by Application in 2025 Figure 34. North America Inhaled NO Vasodilator Sales Market Share in Value by Application in 2025 Figure 35. Europe Inhaled NO Vasodilator Sales Market Share in Volume by Application in 2025 Figure 36. Europe Inhaled NO Vasodilator Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Inhaled NO Vasodilator Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Inhaled NO Vasodilator Sales Market Share in Value by Application in 2025 Figure 39. Latin America Inhaled NO Vasodilator Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Inhaled NO Vasodilator Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Inhaled NO Vasodilator Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Inhaled NO Vasodilator Sales Market Share in Value by Application in 2025 Figure 43. North America Inhaled NO Vasodilator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Inhaled NO Vasodilator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Inhaled NO Vasodilator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Inhaled NO Vasodilator Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Inhaled NO Vasodilator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Inhaled NO Vasodilator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Inhaled NO Vasodilator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Inhaled NO Vasodilator Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Inhaled NO Vasodilator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Inhaled NO Vasodilator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Inhaled NO Vasodilator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Inhaled NO Vasodilator Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Inhaled NO Vasodilator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Inhaled NO Vasodilator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Inhaled NO Vasodilator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Inhaled NO Vasodilator Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Inhaled NO Vasodilator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Inhaled NO Vasodilator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Inhaled NO Vasodilator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Inhaled NO Vasodilator Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Inhaled NO Vasodilator Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Inhaled NO Vasodilator Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • PPHN
  • ARDS
  • Others
Companies covered
  • Air Liquide
  • BOC Healthcare (Linde Group)
  • Mallinckrodt
  • Praxair (Linde plc)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaled NO Vasodilator Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhaled NO Vasodilator Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhaled NO Vasodilator Market by Type
  6. 1.3.1 800 ppm
  7. 1.3.2 100 ppm
  8. 1.3.3 Others
  9. 1.4 Global Inhaled NO Vasodilator Market Size by Type
  10. 1.4.1 Global Inhaled NO Vasodilator Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Inhaled NO Vasodilator Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Inhaled NO Vasodilator Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Inhaled NO Vasodilator Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Inhaled NO Vasodilator Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Inhaled NO Vasodilator Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Inhaled NO Vasodilator Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Inhaled NO Vasodilator Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhaled NO Vasodilator Industry Trends
  2. 2.2 Inhaled NO Vasodilator Industry Drivers
  3. 2.3 Inhaled NO Vasodilator Industry Opportunities and Challenges
  4. 2.4 Inhaled NO Vasodilator Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhaled NO Vasodilator Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhaled NO Vasodilator Sales (2021-2026)
  3. 3.3 Global Top Players by Inhaled NO Vasodilator Price (2021-2026)
  4. 3.4 Global Inhaled NO Vasodilator Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaled NO Vasodilator Major Company Production Sites & Headquarters
  6. 3.6 Global Inhaled NO Vasodilator Company, Product Type & Application
  7. 3.7 Global Inhaled NO Vasodilator Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaled NO Vasodilator Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaled NO Vasodilator Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaled NO Vasodilator Tier 1, Tier 2, and Tier 3
4 Inhaled NO Vasodilator Regional Status and Outlook
  1. 4.1 Global Inhaled NO Vasodilator Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhaled NO Vasodilator Historic Market Size by Region
  3. 4.2.1 Global Inhaled NO Vasodilator Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhaled NO Vasodilator Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhaled NO Vasodilator Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhaled NO Vasodilator Forecasted Market Size by Region
  7. 4.3.1 Global Inhaled NO Vasodilator Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhaled NO Vasodilator Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhaled NO Vasodilator Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhaled NO Vasodilator by Application
  1. 5.1 Inhaled NO Vasodilator Market by Application
  2. 5.1.1 PPHN
  3. 5.1.2 ARDS
  4. 5.1.3 Others
  5. 5.2 Global Inhaled NO Vasodilator Market Size by Application
  6. 5.2.1 Global Inhaled NO Vasodilator Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inhaled NO Vasodilator Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inhaled NO Vasodilator Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inhaled NO Vasodilator Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inhaled NO Vasodilator Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inhaled NO Vasodilator Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inhaled NO Vasodilator Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inhaled NO Vasodilator Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Air Liquide
  2. 6.1.1 Air Liquide Company Information
  3. 6.1.2 Air Liquide Business Overview
  4. 6.1.3 Air Liquide Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Air Liquide Inhaled NO Vasodilator Product Portfolio
  6. 6.1.5 Air Liquide Recent Developments
  7. 6.2 BOC Healthcare (Linde Group)
  8. 6.2.1 BOC Healthcare (Linde Group) Company Information
  9. 6.2.2 BOC Healthcare (Linde Group) Business Overview
  10. 6.2.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio
  12. 6.2.5 BOC Healthcare (Linde Group) Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mallinckrodt Inhaled NO Vasodilator Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Praxair (Linde plc)
  20. 6.4.1 Praxair (Linde plc) Company Information
  21. 6.4.2 Praxair (Linde plc) Business Overview
  22. 6.4.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio
  24. 6.4.5 Praxair (Linde plc) Recent Developments
7 North America by Country
  1. 7.1 North America Inhaled NO Vasodilator Sales by Country
  2. 7.1.1 North America Inhaled NO Vasodilator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhaled NO Vasodilator Sales by Country (2021-2026)
  4. 7.1.3 North America Inhaled NO Vasodilator Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhaled NO Vasodilator Market Size by Country
  6. 7.2.1 North America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhaled NO Vasodilator Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhaled NO Vasodilator Sales by Country
  2. 8.1.1 Europe Inhaled NO Vasodilator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhaled NO Vasodilator Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhaled NO Vasodilator Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhaled NO Vasodilator Market Size by Country
  6. 8.2.1 Europe Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhaled NO Vasodilator Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhaled NO Vasodilator Sales by Country
  2. 9.1.1 Asia-Pacific Inhaled NO Vasodilator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhaled NO Vasodilator Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhaled NO Vasodilator Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhaled NO Vasodilator Market Size by Country
  6. 9.2.1 Asia-Pacific Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhaled NO Vasodilator Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhaled NO Vasodilator Sales by Country
  2. 10.1.1 South America Inhaled NO Vasodilator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhaled NO Vasodilator Sales by Country (2021-2026)
  4. 10.1.3 South America Inhaled NO Vasodilator Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhaled NO Vasodilator Market Size by Country
  6. 10.2.1 South America Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhaled NO Vasodilator Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhaled NO Vasodilator Sales by Country
  2. 11.1.1 Middle East and Africa Inhaled NO Vasodilator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhaled NO Vasodilator Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhaled NO Vasodilator Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhaled NO Vasodilator Market Size by Country
  6. 11.2.1 Middle East and Africa Inhaled NO Vasodilator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhaled NO Vasodilator Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhaled NO Vasodilator Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhaled NO Vasodilator Value Chain Analysis
  2. 12.1.1 Inhaled NO Vasodilator Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhaled NO Vasodilator Production Mode & Process
  7. 12.2 Inhaled NO Vasodilator Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhaled NO Vasodilator Distributors
  10. 12.2.3 Inhaled NO Vasodilator Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst